NCT02915523 2024-01-10Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian CancerSyndax PharmaceuticalsPhase 1/2 Completed140 enrolled 25 charts
NCT03924245 2022-04-04Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube CancersVanderbilt-Ingram Cancer CenterPhase 1 Terminated3 enrolled